Last updated on December 2019

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

Brief description of study

The purpose of this study is to compare the effect of the study drug tirzepatide to insulin degludec on blood sugar levels in participants with type 2 diabetes. The study will last about 59 weeks and may include up to 22 visits.

Clinical Study Identifier: NCT03882970

Find a site near you

Start Over

San Miguel Medical

Trujillo Alto, Puerto Rico
  Connect »

GCM Medical Group PSC

San Juan, Puerto Rico
  Connect »

Latin Clinical Trial Center

San Juan, Puerto Rico
  Connect »